Mild Cognitive Impairment Mci clinical trials

Explore recruiting mild cognitive impairment mci clinical trials.

Recruiting mild cognitive impairment mci studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mild Cognitive Impairment Mci trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia

Finland, Spain, Germany, Sweden, France, Denmark +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia

Denmark, Germany, Finland, Poland, Czechia, Sweden +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicenter, Randomized, Double-masked, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Effects of NTRX-07 in Subjects with Mild Cognitive Impairment (MCI) or Mild to Moderate Alzheimer’s Disease (AD) (SPPN-AD)

Poland, Hungary, Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

A single-center, self-controlled, single-arm pilot clinical trial to assess the effect of lamivudine (3TC) on neurocognitive impairment biomarkers and type-I IFN (interferon)-stimulated genes in the plasma of patients with Mild Cognitive Impairment (MCI)

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomised double-blind placebo-controlled clinical trial investigating the effect and safety of oral semaglutide in subjects with early Alzheimer´s disease (EVOKE plus)

Romania, Bulgaria, Belgium, Croatia, France, Greece +15 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomised double-blind placebo-controlled clinical study investigating the effects of semaglutide s.c. once-weekly versus placebo on central and peripheral inflammation in participants with Alzheimer’s disease.

Denmark, Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Mild Cognitive Impairment Mci trials by city

Mild Cognitive Impairment Mci in Toronto Mild Cognitive Impairment Mci in Vancouver Mild Cognitive Impairment Mci in Montreal Mild Cognitive Impairment Mci in Calgary Mild Cognitive Impairment Mci in Edmonton Mild Cognitive Impairment Mci in Ottawa Mild Cognitive Impairment Mci in Winnipeg Mild Cognitive Impairment Mci in Quebec City Mild Cognitive Impairment Mci in Hamilton Mild Cognitive Impairment Mci in Kitchener Mild Cognitive Impairment Mci in London Mild Cognitive Impairment Mci in Halifax Mild Cognitive Impairment Mci in New York Mild Cognitive Impairment Mci in Los Angeles Mild Cognitive Impairment Mci in Chicago Mild Cognitive Impairment Mci in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease